Masami Eigyo

559 total citations
25 papers, 484 citations indexed

About

Masami Eigyo is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Masami Eigyo has authored 25 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 10 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Masami Eigyo's work include Neuroscience and Neuropharmacology Research (7 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroendocrine regulation and behavior (4 papers). Masami Eigyo is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neuropeptides and Animal Physiology (7 papers) and Neuroendocrine regulation and behavior (4 papers). Masami Eigyo collaborates with scholars based in Japan. Masami Eigyo's co-authors include Akira Matsushita, Goro Katsuura, Akira Sugawara, Hiroshi Itoh, Yoshihiko Saito, Hiroo Imura, Takayuki Yamada, Shozo Shiono, Makoto Sakamoto and Narito Morii and has published in prestigious journals such as Brain Research, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Masami Eigyo

25 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masami Eigyo Japan 13 201 152 122 89 67 25 484
C. Mermet France 13 309 1.5× 280 1.8× 113 0.9× 57 0.6× 39 0.6× 18 682
Hiromi Tsushima Japan 15 136 0.7× 161 1.1× 35 0.3× 172 1.9× 60 0.9× 43 481
Inmaculada Banegas Spain 15 215 1.1× 120 0.8× 177 1.5× 93 1.0× 54 0.8× 48 567
Nobuharu Yamaguchi Canada 15 328 1.6× 277 1.8× 167 1.4× 74 0.8× 19 0.3× 53 671
Michael J. Meldrum United States 14 260 1.3× 193 1.3× 104 0.9× 46 0.5× 28 0.4× 32 525
Maximiliano Ibarra Mexico 11 213 1.1× 287 1.9× 85 0.7× 26 0.3× 29 0.4× 20 512
Judith A. Kiritsy‐Roy United States 12 365 1.8× 211 1.4× 91 0.7× 45 0.5× 57 0.9× 18 606
J. S. Hutchinson Australia 17 206 1.0× 319 2.1× 381 3.1× 93 1.0× 48 0.7× 39 764
Jana Slavı́ková Czechia 14 245 1.2× 253 1.7× 157 1.3× 26 0.3× 20 0.3× 38 549
James Tarver United States 8 160 0.8× 98 0.6× 69 0.6× 20 0.2× 15 0.2× 13 417

Countries citing papers authored by Masami Eigyo

Since Specialization
Citations

This map shows the geographic impact of Masami Eigyo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masami Eigyo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masami Eigyo more than expected).

Fields of papers citing papers by Masami Eigyo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masami Eigyo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masami Eigyo. The network helps show where Masami Eigyo may publish in the future.

Co-authorship network of co-authors of Masami Eigyo

This figure shows the co-authorship network connecting the top 25 collaborators of Masami Eigyo. A scholar is included among the top collaborators of Masami Eigyo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masami Eigyo. Masami Eigyo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawasaki, Kazuo, Masami Eigyo, Masato Ikeda, et al.. (1996). A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 20(8). 1413–1425. 23 indexed citations
2.
Takada, Susumu, Makoto Adachi, Toshio Fujishita, et al.. (1996). Synthesis and Structure−Activity Relationships of Fused Imidazopyridines:  A New Series of Benzodiazepine Receptor Ligands. Journal of Medicinal Chemistry. 39(14). 2844–2851. 23 indexed citations
3.
Eigyo, Masami, et al.. (1994). Pharmacological Studies on a New Dihydrothienopyridine Calcium Antagonist, S-312-d 5th Communication: Anticonvulsant Effects in Mice.. The Japanese Journal of Pharmacology. 65(2). 175–177. 9 indexed citations
4.
Eigyo, Masami, et al.. (1992). Systematic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils. European Journal of Pharmacology. 214(2-3). 149–158. 14 indexed citations
5.
Katoh, Akira, et al.. (1992). Ischemia-induced irreversible deficit of memory function in gerbils. Brain Research. 577(1). 57–63. 49 indexed citations
6.
Shinohara, Shunji, et al.. (1992). Inhibitory effect of CCK-8 and ceruletide on glutamate-induced rises in intracellular free calcium concentrations in rat neuron cultures. Brain Research. 588(2). 223–228. 10 indexed citations
7.
Katsuura, Goro, et al.. (1992). A possible involvement of CCK-A receptor in ceru1etide-induced protection against neuronal cell death following cerebral ischemia in mongolian gerbils. The Japanese Journal of Pharmacology. 58. 253–253. 4 indexed citations
8.
Eigyo, Masami, et al.. (1992). Systemic administration of a cholecystokinin analogue, ceruletide, protects against ischemia-induced neurodegeneration in gerbils. European Journal of Pharmacology. 219(3-4). 487–489. 1 indexed citations
9.
10.
Ikeda, Masato, et al.. (1989). Inhibitory effect of ceruletide on haloperidol-induced catalepsy in rats. Peptides. 10(4). 779–783. 5 indexed citations
11.
Yamada, Takayuki, Kazuwa Nakao, Hiroshi Itoh, et al.. (1989). Effects of Naloxone on Vasopressin Secretion in Conscious Rats: Evidence for Inhibitory Role of Endogenous Opioid Peptides in Vasopressin Secretion*. Endocrinology. 125(2). 785–790. 25 indexed citations
12.
Yamada, Takayuki, Kazuwa Nakao, Hiroshi Itoh, et al.. (1988). Inhibitory Action of Leumorphin on Vasopressin Secretion in Conscious Rats*. Endocrinology. 122(3). 985–990. 15 indexed citations
13.
Matsushita, Akira, et al.. (1988). Activation of brain function by S-135, a benzodiazepine receptor inverse agonist. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12(6). 951–966. 5 indexed citations
14.
Matsushita, Akira, et al.. (1987). BRAIN ACTIVATING PROPERTIES OF A THIENYLPYRAZOLOQUINOLINE DERIVATIVE. Journal of Pharmacobio-Dynamics. 10(7). 1 indexed citations
15.
Takada, Susumu, et al.. (1987). A new thienylpyrazoloquinoline: a potent and orally active inverse agonist to benzodiazepine receptors. Journal of Medicinal Chemistry. 30(3). 454–455. 12 indexed citations
16.
Yamada, Takayuki, Kazuwa Nakao, Narito Morii, et al.. (1986). Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in concious rats. European Journal of Pharmacology. 125(3). 453–456. 82 indexed citations
17.
Katsuura, Goro, Narito Morii, Hiroshi Itoh, et al.. (1986). Inhibitory effect of centrally administered atrial natriuretic polypeptide on the brain dopaminergic system in rats. European Journal of Pharmacology. 131(2-3). 171–177. 41 indexed citations
18.
Itoh, Hiroshi, Kazuwa Nakao, Narito Morii, et al.. (1986). Central action of atrial natriuretic polypeptide on blood pressure in conscious rats. Brain Research Bulletin. 16(5). 745–749. 62 indexed citations
19.
Hirose, Katsumi, et al.. (1984). . Folia Pharmacologica Japonica. 84(1). 109–154. 3 indexed citations
20.
Yoshizaki, Toshio, et al.. (1982). Differential effects of sulpiride and metoclopramide on brain. Naunyn-Schmiedeberg s Archives of Pharmacology. 321(3). 190–194. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Mermet Breakdown of academic impact, for papers by Hiromi Tsushima Breakdown of academic impact, for papers by Inmaculada Banegas Breakdown of academic impact, for papers by Nobuharu Yamaguchi Breakdown of academic impact, for papers by Michael J. Meldrum Breakdown of academic impact, for papers by Maximiliano Ibarra Breakdown of academic impact, for papers by Judith A. Kiritsy‐Roy Breakdown of academic impact, for papers by J. S. Hutchinson Breakdown of academic impact, for papers by Jana Slavı́ková Breakdown of academic impact, for papers by James Tarver
Rankless by CCL
2026